Vitreous Amino Acid Concentrations in Patients With Glaucoma Undergoing Vitrectomy
Open Access
- 1 February 2003
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 121 (2) , 183-188
- https://doi.org/10.1001/archopht.121.2.183
Abstract
GLAUCOMA IS an important cause of blindness worldwide.1 It is the second leading cause of blindness in the United States and is the leading cause among older African Americans.2 There is evidence that lowering intraocular pressure slows the progression of glaucoma.3-5 Recently, much research has been directed at the elucidation of biochemical and molecular mechanisms of optic nerve damage in glaucoma, with a hope of finding additional treatment modalities.Keywords
This publication has 1 reference indexed in Scilit:
- The Glaucoma Laser Trial (GLT) and Glaucoma Laser Trial Follow-up Study: 7. ResultsAmerican Journal of Ophthalmology, 1995